Recommended Pages at formularyjournal.modernmedicine.com
Topiramate reclassified as Category D due to potential link to oral clefts in newborns - - Formulary
formularyjournal.modernmedicine.com — “FDA announced that it was reclassifying topiramate from a Pregnancy Category C to a Pregnancy Category D drug.” View full resource at formularyjournal.modernmedicine.com
Most Recently Shared on August 3, 2011 at 1:29 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Topiramate reclassified as Category D due to potential link to oral clefts in newborns http://bit.ly/qYV0rY
Breaking News: Diabetes, specialty drugs continue to drive growth in drug spending - - Formulary
formularyjournal.modernmedicine.com — “For the fourth consecutive year, diabetes therapy topped the list of contributors to drug use trends in therapeutic categories, contributing 16.1% to overall growth in drug spending in 2010 due to an increasing number of patients, according to the recently released 2011 Medco Drug Trend Report, which tracks utilization and spending.” View full resource at formularyjournal.modernmedicine.com
Most Recently Shared on May 18, 2011 at 7:23 pm By:
Diabetes, specialty drugs continue to drive growth in drug spending (Formulary) http://bit.ly/j3zck8
Technosphere insulin: An inhaled mealtime insulin for the treatment of type 1 and type 2 diabetes mellitus - - Formulary
formularyjournal.modernmedicine.com — “Technosphere insulin is an inhaled form of regular human insulin with a rapid onset of action (~15 min) that is being considered for approval for the treatment of type 1 and type 2 diabetes mellitus. Technosphere insulin has shown efficacy in decreasing the level of glycosylated hemoglobin in a dose-dependent manner.” View full resource at formularyjournal.modernmedicine.com
Most Recently Shared on January 27, 2011 at 8:45 pm By:
Technosphere insulin: An inhaled mealtime insulin for the treatment of type 1 and type 2 diabetes mellitus http://bit.ly/gJVsbT
Formulary - Drug-related clinical news & analysis for hospital & managed-care P&T members
formularyjournal.modernmedicine.com — “Medication/Formulary-related peer-reviewed articles, clinical news & analysis for hospital and managed-care P&T decision-makers. FDA approvals, pharmacy & therapeutics management & drug reviews as well as pipeline preview & meeting coverage” View full resource at formularyjournal.modernmedicine.com
